Tribulus terrestris: Research, Dosing, and Where to Buy in 2026
A research-first profile for Tribulus terrestris (tribulous teristus, Turb), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Tribulus terrestris is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for Tribulus terrestris, each linked to its source.
- Also indexed as tribulous teristus, Turb.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Tribulus terrestris?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Tribulus terrestris Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy Tribulus terrestris in 2026
No tracked vendor recommendations for Tribulus terrestris yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Tribulus terrestris. Each line links to the original source.
- "The outcomes of continuous variables were aggregated into the mean difference (MD) with corresponding 95% confidence intervals (95% CI) utilizing random-effects models." · Suharyani S et al, 2026 PubMed
- "Additionally, on both the IIEF-5 [MD 3.23 (95%CI 1.89, 4.58), p < 0.00001] and IIEF-15 [MD 14.44 (95%CI 5.75, 23.14), p = 0.001], Tribulus terrestris outperformed placebo." · Suharyani S et al, 2026 PubMed
- "The Jadad score revealed low methodological quality for 50% of the studies." · Vilar Neto J et al, 2025 PubMed
- "In addition, the extracts were able to induce death of more than 50% of human tumor cell lines." · Figueiredo C et al, 2021 PubMed
Research and Studies
8 PubMed-indexed papers reference Tribulus terrestris. Top 8 shown.
Legal Status
Tribulus terrestris is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Tribulus terrestris FDA-approved?
Tribulus terrestris is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on Tribulus terrestris?
8 PubMed-indexed paper(s) reference Tribulus terrestris in our current research feed. See the Research and Studies section above for citations.